
Genpact has a strong track record of delivering consistent financial performance, with a compound annual growth rate (CAGR) of 15% over the past five years.
The company's growth is driven by its focus on digital transformation and its ability to adapt to changing client needs. This has enabled Genpact to expand its services and offerings, increasing its revenue streams.
Genpact has a significant presence in the global market, with operations in over 25 countries and a client base that includes many Fortune 500 companies. This global reach has helped the company to diversify its revenue streams and reduce its dependence on any one market or industry.
Genpact's financial performance has also been supported by its ability to maintain a strong cash position, with a cash and cash equivalents balance of over $1 billion at the end of 2022.
If this caught your attention, see: Global X Funds Stock Price
Financial Information
Genpact's financial health is reflected in its current ratio of 1.53, indicating that it has sufficient liquid assets to cover its short-term debts. This ratio is a crucial indicator of a company's ability to meet its financial obligations.
Discover more: Current Financial Market Sentiment Indicators
The company's debt levels are manageable, with a Debt / Equity ratio of 0.59. This suggests that Genpact has a relatively low level of debt compared to its equity.
Here are some key financial metrics for Genpact:
Genpact's return on equity (ROE) is a strong 21.86%, indicating that it generates significant profits from its shareholders' investment.
Income Statement
Genpact's income statement reveals some impressive numbers. The company had revenue of $4.93 billion in the last 12 months.
Breaking down the revenue, we see that Genpact earned $538.30 million in profits. This is a significant amount, and it's likely that the company's management team is proud of this achievement.
One key metric to look at is earnings per share (EPS), which was $3.01. This means that for every share of Genpact stock, the company earned $3.01 in profits.
Here's a summary of Genpact's income statement:
Genpact's operating income was $731.93 million, which is a significant portion of the company's revenue.
Assets
Assets are a crucial part of your financial picture, and understanding what they are and how to manage them is essential for making smart financial decisions.
Cash and other liquid assets are a type of asset that can be easily converted into cash, such as savings accounts, checking accounts, and money market funds. These assets provide a safety net in case of emergencies or unexpected expenses.
Investment assets, like stocks and bonds, have the potential to grow in value over time, but they also come with risks. For example, stocks can be volatile and may lose value in a downturn.
Retirement accounts, such as 401(k)s and IRAs, are a type of investment asset specifically designed for long-term savings. Contributions to these accounts may be tax-deductible, and the funds grow tax-deferred.
Real estate, including your primary residence and any rental properties, is a type of asset that can provide a steady income stream through rental income or appreciation in value over time.
Expand your knowledge: Elcid Investment Share Price History
Financial Performance
Genpact's financial performance is a key aspect to consider when evaluating the stock. The company's return on equity (ROE) is 21.86%, indicating a strong ability to generate profits from shareholder equity.
Genpact's financial efficiency is also noteworthy, with a return on invested capital (ROIC) of 10.98% and a return on capital employed (ROCE) of 18.69%. This suggests that the company is effectively utilizing its capital to drive growth.
The company's revenue per employee is $35,207, and profits per employee are $3,845, indicating a high level of productivity and efficiency in its operations. With an employee count of 140,000, Genpact is a large and complex organization, but its financial performance suggests that it is well-managed and effective.
Here are some key financial metrics for Genpact:
Financial Efficiency
Financial Efficiency is a crucial aspect of a company's overall financial health. A high Return on Equity (ROE) indicates that a company is generating significant profits from its shareholders' equity. In the case of Genpact, the ROE is 21.86%.
Check this out: General Growth Company
Return on Assets (ROA) measures a company's ability to generate profits from its assets. Genpact's ROA is 8.73%, which is a respectable figure. However, it's worth noting that a higher ROA is generally better.
Return on Invested Capital (ROIC) is a key metric for evaluating a company's ability to generate returns from its invested capital. Genpact's ROIC is 10.98%, which is a good sign. This means that for every dollar invested, the company is generating over 10 cents in returns.
Here's a breakdown of Genpact's financial efficiency metrics:
Genpact's high ROCE of 18.69% suggests that the company is generating significant returns from its employed capital. This is a positive sign for investors and stakeholders.
Price History & Performance
Genpact's share price has experienced some fluctuations over the years, with a 52-week high of US$56.76 and a low of US$37.82.
The current share price is US$40.29, indicating a decrease of 1.99% in the last month. In contrast, the stock price has increased by 5.44% in the last year.
Suggestion: Us Mortgage Rates Impact Activity
Genpact's beta is 0.90, meaning its price volatility has been lower than the market average. This suggests that the company's stock price has been relatively stable compared to other companies.
Here's a summary of Genpact's price history and performance over the past few years:
Genpact's price performance has been quite impressive over the long term, with a 140.54% increase since its IPO. However, the company's stock price has experienced some volatility in the short term.
Stock Details
Genpact has a significant number of shares outstanding, with 174.27 million shares currently in circulation.
The number of shares has actually decreased by 2.14% over the past year, indicating a slight decline in the company's share count.
Genpact's share price has also seen some fluctuations, with a current price of $40.29 and a 52-week high of $56.76.
Here's a quick rundown of Genpact's share price movements over the past year:
Stock Price
Genpact's stock price has been relatively stable over the past year, with a 5.44% increase in share price. This is a significant improvement from the previous year.
A fresh viewpoint: Krugerrand Value by Year
The company's beta is 0.90, indicating that its price volatility has been lower than the market average. This suggests that Genpact's stock price is less affected by market fluctuations.
Here are some key statistics about Genpact's stock price:
The current share price is $40.29, which is within the 52-week range of $37.82 to $56.76.
Short Selling Information
As you delve into the world of stock details, it's essential to understand the concept of short selling. Short selling is when investors sell shares they don't own, with the expectation of buying them back later at a lower price to make a profit.
The latest short interest is a crucial metric to keep an eye on. In this case, the latest short interest is 7.16 million shares.
This number represents the total number of shares that have been sold short. To put it into perspective, that's a significant portion of the outstanding shares, making up 4.11% of the total.
Recommended read: Bkkt Short Interest
The short interest has actually decreased from the previous month, when it stood at 6.95 million shares. This could indicate a decrease in bearish sentiment among investors.
Another key metric to consider is the short ratio, which measures the number of days it would take to cover all the short positions. In this case, the short ratio is 3.70 days to cover.
Here's a summary of the short selling information:
Dividends and Returns
Genpact's shareholder returns have been a mixed bag. The company exceeded the US Professional Services industry, which returned -5.8% over the past year, but underperformed the US Market, which returned 16.3% over the same period.
In a broader context, Genpact's returns are comparable to the S&P, with both experiencing a 5.84% gain over the past year. However, the S&P has outperformed Genpact over the long term, with a 202% gain since its IPO compared to Genpact's 202% gain.
Here's a comparison of Genpact's returns to the S&P over different time periods:
Shareholder Returns
Let's take a closer look at shareholder returns. Genpact (G) exceeded the US Professional Services industry, which returned -5.8% over the past year. This is a notable achievement.
The company's performance is also compared to the broader market. Unfortunately, Genpact underperformed the US Market, which returned 16.3% over the past year.
Here's a snapshot of Genpact's performance over different time periods:
Genpact's 5-year annualized return is +3.06%, which is lower than the S&P's +14.29% over the same period.
Fourth Quarter Dividend Announced
The fourth quarter dividend was announced on October 15th, with a payment date of December 1st.
This means that investors who own shares as of the record date will receive the dividend payment.
Taxes
Genpact has paid a significant amount in taxes over the past year, totaling $171.69 million.
This substantial tax payment is a notable expense for the company, but it's essential to consider the broader context of their financial performance.
Genpact's effective tax rate is 24.18%, which indicates that a substantial portion of their income has been subject to taxation.
This tax rate is a crucial factor in understanding the company's overall financial health and profitability.
Here is a breakdown of Genpact's tax payments and effective tax rate:
Genpact's tax payments and effective tax rate are important metrics to consider when evaluating the company's financial performance and potential for future growth.
Intriguing read: Tax Equity Market
Financial Health
Genpact's financial health is a mixed bag. The company has a current ratio of 1.53, which is a good sign that it can cover its short-term debts. However, its debt-to-equity ratio of 0.59 indicates that it's relying more on debt than equity to finance its operations.
Genpact's cash position is also a concern, with a net cash position of -$863.71 million or -$4.96 per share. This means that the company is currently in a net debt position, which could be a challenge for its financial health.
Take a look at this: Market Value of Sun Life Financial Common Shares
Here's a summary of Genpact's key financial ratios:
Genpact's financial health is a complex issue that requires a closer look at its balance sheet and income statement. While it has some positive signs, such as a good current ratio, it also has some red flags, like its net cash position.
Financial Position
The company's financial position is a crucial aspect of its overall health. The current ratio is 1.53, indicating that the company has sufficient liquid assets to cover its short-term liabilities.
The quick ratio is 1.39, which is slightly lower than the current ratio. This suggests that the company's ability to pay its short-term debts is not as strong as its ability to cover its liabilities.
Debt is a significant concern for the company, with a debt-to-equity ratio of 0.59. This means that for every dollar of equity, the company has 59 cents of debt.
The company's debt burden is substantial, with a debt-to-EBITDA ratio of 1.73 and a debt-to-free cash flow ratio of 2.71. This indicates that the company's ability to service its debt is a challenge.
For more insights, see: Current Market Pe Ratio
Here's a summary of the company's financial position:
The company's interest coverage ratio is 9.26, which suggests that it has a strong ability to pay its interest expenses. However, this ratio should be monitored closely to ensure the company's debt servicing ability remains robust.
A different take: Simon Company Stock
Price Volatility
Genpact's stock price has been relatively stable in the past year, with a beta of 0.90 indicating lower price volatility compared to the market average. This suggests that the company's stock price movements have been less extreme than those of the overall market.
The stock price has increased by +3.44% in the last 52 weeks, which is a relatively modest gain. However, it's worth noting that the 52-week high is US$56.76, while the 52-week low is US$37.82, indicating a decent range of price movement.
Genpact's average weekly movement is 3.1%, which is lower than the industry average of 5.6% and the market average of 6.5%. This suggests that the company's stock price is relatively stable compared to its peers.
Here's a comparison of Genpact's price volatility with the US market:
Overall, Genpact's price volatility appears to be relatively low compared to the US market, which is a positive sign for investors looking for stability.
Enterprise Valuation
The enterprise valuation of Genpact stock is a key metric to consider when evaluating its value. The stock's EV/EBITDA ratio is 9.61.
This means that the market is valuing Genpact's earnings before interest, taxes, depreciation, and amortization (EBITDA) at a multiple of 9.61 times its enterprise value (EV).
The EV/FCF ratio, on the other hand, is 13.94. This indicates that the market is valuing Genpact's free cash flow (FCF) at a multiple of 13.94 times its enterprise value.
Here's a summary of the key enterprise valuation metrics for Genpact stock:
These metrics can provide valuable insights into the stock's value and help investors make informed decisions.
Ratios and Scores
Genpact's valuation ratios are worth taking a closer look at. The trailing PE ratio is 13.38 and the forward PE ratio is 10.98.
Genpact's PEG ratio is 1.20, which indicates that the stock is slightly overvalued. The company's PEG ratio is a key metric to consider when evaluating its growth prospects.
Here are Genpact's valuation ratios at a glance:
Genpact's Altman Z-Score is 3.59 and its Piotroski F-Score is 6, indicating a moderate level of financial health.
Ratios
Ratios are a crucial part of evaluating a company's financial health and performance. The trailing PE ratio is 13.38, a significant indicator of a company's stock price relative to its earnings.
The forward PE ratio, on the other hand, is 10.98, indicating a slightly more optimistic outlook for the company's future earnings. Genpact's PEG ratio is 1.20, which can be a useful metric for comparing the company's valuation to its growth rate.
Ratios can also provide insight into a company's return on investment. In Q2 2025, Genpact's Return On Assets was 10.27%, a decrease of 3.1% from the previous year. In contrast, the Return On Invested Capital was 12.72%, an increase of 0.9% from the previous year.
Here's a summary of Genpact's ratios:
Scores
Genpact has an Altman Z-Score of 3.59, which is a relatively low score indicating potential financial distress.
The Piotroski F-Score of 6 for Genpact is a decent score, suggesting that the company has a relatively stable financial situation.
For your interest: Genpact Company Ceo
Analyst Insights
Genpact's financials have been a mixed bag, with revenue growth slowing down in recent years.
The company's net income margin has been on a downward trend, from 8.6% in 2018 to 5.5% in 2020.
Genpact has been investing heavily in digital transformation, which has led to an increase in research and development expenses.
The company's return on equity (ROE) has been declining, from 17.1% in 2018 to 12.3% in 2020.
Genpact has a strong track record of paying dividends, with a five-year dividend growth rate of 10.3%.
The company's debt-to-equity ratio has been increasing, from 0.23 in 2018 to 0.35 in 2020.
Frequently Asked Questions
Who is Genpact owned by?
Genpact is not owned by a parent company, having spun off from GE Capital in 2005. It is now a publicly traded company.
What is the future outlook for Genpact?
Genpact is projected to reach $5.9 billion in revenue and $669.6 million in earnings by 2028, driven by 6.2% yearly revenue growth. This growth potential suggests a fair value of $53.00, indicating a 20% upside to its current price.
What is the price target for Genpact?
The average price target for Genpact is $51.75, representing a 14.21% increase from its current price of $45.31. This estimate is based on 9 analyst forecasts.
Featured Images: pexels.com


